Skip to content

Observation of curative effect of stellate ganglion block on allergic rhinitis

Observation of curative effect of stellate ganglion block on allergic rhinitis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078572
Enrollment
Unknown
Registered
2023-12-12
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Men or women between the ages of 18 and 65 who have no childbearing requirements; ? Clear allergy symptoms from exposure to pollen season, house dust, or pets; ? Meet the diagnostic criteria for allergic rhinitis, positive for at least one allergen by skin prick test (SPT) and/or sero-specific and/or nasal irritation test; ? Sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: ? Severe or poorly controlled asthma; ? Severe underlying diseases, including liver disease, kidney disease, hematological disease, cardiovascular disease, etc; ? Acute and chronic respiratory diseases within one month, such as influenza, bronchiectasis, chronic obstructive pulmonary disease, etc; ? Pregnant and lactating women; ? Inability to cooperate, communication barriers (language barriers, severe visual or auditory impairments); ? Participating in other clinical researchers.

Design outcomes

Primary

MeasureTime frame
Rhinitis Quality of Life Questionnaire;Total score of nasal symptoms;ILC2;IL-4;

Secondary

MeasureTime frame
Pathological section of nasal mucosa;IL-5;IL-13;Partial photographs of the nasal mucosa;IgE;

Countries

China

Contacts

Public ContactWeiwei Zhang

Shanxi Bethune Hospital

sxdyyzww@163.com+86 152 3412 1313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026